Amino acid replacement: K554term.
Nucleotide substitution: A?T.
A15038168T
A?T
K553term | hbs-PA; K553term | hbs-PB; K553term | hbs-PC
K554term
hbs459/+ dominantly enhances the Scer\GAL4hs.2sev>hbsVDRC.cUa-induced planar cell polarity phenotype in the eye.
hbs459/Df(2R)ED2423 mutants display a reduction in the number of notal microchaetae compared with wild-type.
Stage 12 hbs459/Df(2R)X28 or hbs459/hbs2593 embryos have a reduction in the number of visceral muscle progenitors. hbs459/Df(2R)X28, or hbs459/hbs2593 embryos The overall pattern or somatic muscles is normal, though there is a partial fusion block in embryos (especially around the heart). The unfused myoblasts can still extend filopodia. Mutant embryos also show a gut phenotype consisting of an enlarged first gut chamber, which pushes the dorsal muscles and heart upwards.
hbs459 is a suppressor of abnormal planar polarity phenotype of Scer\GAL4GMR.PF, cindrRNAi.PC.PD.UAS
hbs459/Df(2R)ED2423 has notal microchaeta phenotype, enhanceable by Psn9/Psn143
hbs459/hbs2593 has embryonic myoblast phenotype, enhanceable by sns[+]/snsXB3
hbs459/hbs2593 has embryonic myoblast phenotype, enhanceable by sns[+]/snsD1
hbs459/hbs2593 has embryonic myoblast phenotype, suppressible by snsXB3
hbs459/hbs2593 has embryonic midgut chamber 1 phenotype, suppressible by snsXB3
hbs459/hbs2593 has visceral muscle primordium phenotype, suppressible by snsXB3
hbs459/hbs2593 has presumptive embryonic/larval muscle system phenotype, suppressible by snsXB3
hbs459/hbs[+] is an enhancer of retina phenotype of Arf6GD13822, Dcr-2UAS.cDa, Scer\GAL4GMR.PF
hbs459 is a suppressor of primary pigment cell phenotype of Scer\GAL4GMR.PF, cindrRNAi.PC.PD.UAS
hbs459 is a suppressor of ommatidium phenotype of Scer\GAL4GMR.PF, cindrRNAi.PC.PD.UAS
hbs459 is a suppressor of pigment cell phenotype of Scer\GAL4GMR.PF, cindrRNAi.PC.PD.UAS
hbs459 is a suppressor of secondary pigment cell phenotype of Scer\GAL4GMR.PF, cindrRNAi.PC.PD.UAS
hbs459 is a suppressor of tertiary pigment cell phenotype of Scer\GAL4GMR.PF, cindrRNAi.PC.PD.UAS
dock04723, hbs459 has embryonic myoblast phenotype
hbs459/hbs2593, snsXB3/snsD1 has muscle founder cell | embryonic stage phenotype
Psn9/Psn143 strongly enhances the thoracic bristle loss of hbs459/Df(2R)ED2423 mutants.
The patterning defects in retinas co-expressing Arf51FGD13822 and Dcr-2Scer\UAS.cDa under the control of Scer\GAL4GMR.PF is enhanced by heterozygosity for hbs459.
Pupae heterozygous for hbs459 exhibit mild but consistent suppression of the Scer\GAL4GMR.PF>cindrdsRNA.PC.PD.Scer\UAS phenotype. The prevalence of cone and 1[o] cell defects is decreased and the number of 2[o] and 3[o] cells is reduced to slightly below normal.